Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.9K Sell
168
-23,650
-99% -$2.73M 0.01% 226
2026
Q1
$2.85M Buy
+23,818
New +$3.12M 1.38% 26
2025
Q1
Sell
-41
Closed -$4.76K 276
2024
Q4
$4.76K Buy
+41
New +$5.18K ﹤0.01% 191

Other funds holding XYL

Stance Capital's XYL Position: Q2 2026 in Review

Stance Capital reduced its Xylem (XYL) stake by 99% in Q2 2026, selling an estimated $2.73M and leaving 168 shares worth $19.9K. The position accounts for 0.01% of the portfolio, ranked #226.

Stance Capital first reported a position in XYL in Q4 2024 and has held it in 3 quarters since. The position peaked at $2.85M in Q1 2026. 1,093 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Stance Capital held 168 shares of Xylem worth $19.9K as of Q2 2026.
  • Stance Capital sold 23,650 Xylem shares in Q2 2026, an estimated $2.73M.
  • Xylem made up 0.01% of Stance Capital's portfolio in Q2 2026, its #226 holding.
  • Stance Capital first reported a position in Xylem in Q4 2024 and has held it in 3 quarters since.
  • Stance Capital's Xylem position peaked at $2.85M in Q1 2026.
  • 1,093 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Stance Capital's 13F filing for Q2 2026, filed 14 Aug 2026.